Surmodics now expects fiscal 2024 total revenue to range from $122 M to $124M, Excluding SurVeil DCB license fee revenue, Surmodics expects fiscal 2024 total revenue to range from $118 M to $120M representing an increase of 15% to 17% compared to fiscal 2023. Consensus for FY24 revenue is $119.68M.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRDX: